Radiotheranostics Market Size, Share & Industry Analysis, By Radioisotope (Lutetium-177, Radium-223, Iodine-131, and Others), By Application (Neuroendocrine Tumors, Prostate Cancer, and Others), By End-User (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI108932

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Unit	Value (USD Billion)
Growth Rate	CAGR of 27.90% from 2026-2034
Segmentation	By Radioisotope Lutetium-177 Radium-223 Iodine-131 Others
	By Application Neuroendocrine Tumors Prostate Cancer Others
	By End-User Hospitals & Clinics Diagnostic Centers Others
	By Region North America (By Radioisotope, Application, End-User, and Country) U.S. Canada Europe (By Radioisotope, Application, End-User, and Country/Sub-Region) U.K. Germany France Spain Italy Rest of Europe Asia Pacific (By Radioisotope, Application, End-User, and Country/Sub-Region) Japan China India Australia Rest of Asia Pacific Rest of the World (By Radioisotope, Application, End-User, and Country/Sub-Region)